Zeller H G, Rakotonirina J, Morel B, Pécarrère J L, Lapprand M
Institut Pasteur de Madagascar, BP 1274, 101 Antananarivo, Madagascar.
Arch Inst Pasteur Madagascar. 1996;63(1-2):62-6.
Hepatocellular carcinoma (HCC) etiology and incidence in Madagascar are not well established. The work presented here is the first documented study on HCC in Madagascar. The study was undertaken at the Centre Hospitalier de Soavinandriana, Antananarivo, from October 1995 to October 1996. Hepatocellular carcinoma was reported in 19 out of 22 patients with liver tumor included in the study. In 6 cases, patients developed post alcoholic cirrhosis HCC. Hepatitis B virus markers were detected in 48% of cases (13/19). The HBs Ag was detected in 42% of cases (8/19) in association with HBe Ag in 16% of cases (3/19), and hepatitis C virus antibodies in 11% of cases (2/18). In 3 cases, the etiology remained unknown. Hepatocellular carcinoma appeared the most frequent liver cancer, mainly due to post-hepatitis B cirrhosis. The introduction of hepatitis B vaccine in EPI (Expanded Program of Immunization) is recommended in order to reduce the percentage of hepatitis B virus carriers in the malagasy population and furthermore the incidence of HCC.
马达加斯加肝细胞癌(HCC)的病因及发病率尚未完全明确。本文所呈现的研究是马达加斯加关于HCC的首篇有记录的研究。该研究于1995年10月至1996年10月在塔那那利佛的苏阿维南德里亚纳中心医院开展。在该研究纳入的22例肝脏肿瘤患者中,有19例报告为肝细胞癌。其中6例患者为酒精性肝硬化后发生HCC。48%的病例(13/19)检测到乙型肝炎病毒标志物。42%的病例(8/19)检测到乙肝表面抗原(HBs Ag),16%的病例(3/19)同时检测到乙肝e抗原(HBe Ag),11%的病例(2/18)检测到丙型肝炎病毒抗体。3例患者的病因仍不明。肝细胞癌似乎是最常见的肝癌,主要归因于乙型肝炎后肝硬化。建议在扩大免疫规划(EPI)中引入乙肝疫苗,以降低马达加斯加人群中乙肝病毒携带者的比例,进而降低HCC的发病率。